Tenaya Therapeutics Inc.
TNYA | NASDAQ
$0.69
+$0.02 (+2.40%)
Sep 22, 2026, 9:40 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.11M | 225K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 1.76M | -3.95M | n/a | 2.08M | n/a | n/a | n/a | 2.12M | 2.16M | 2.99M | 2.98M | 2.97M | 2.88M | 2.85M | 2.8M | 1.76M | 1.3M | 1.11M | 1.06M | 998K | 689K |
Gross Profit | 1.11M | -1.54M | 3.95M | n/a | -2.08M | n/a | n/a | n/a | -2.12M | -2.16M | -2.99M | -2.98M | -2.97M | -2.88M | -2.85M | -2.8M | -1.76M | -1.3M | -1.11M | -1.06M | -998K | -689K |
Operating Income | -44.09M | -20.07M | -20.78M | -20.94M | -24.08M | -27.54M | -24.65M | -26.71M | -30.82M | -33.76M | -31.45M | -30.92M | -35.1M | -33.72M | -34.55M | -31.3M | -28.62M | -31.15M | -26.16M | -18.3M | -15.24M | -13.11M |
Interest Income | 697K | 793K | 574K | 658K | 815K | 635K | 812K | 1.08M | 1.39M | 1.45M | 1.47M | 1.78M | 1.84M | 1.97M | 1.04M | 596K | 222K | 99K | 67K | 23K | 9K | 9K |
Pretax Income | -43.39M | -19.27M | -20.18M | -20.28M | -23.28M | -26.86M | -23.84M | -25.63M | -29.43M | -32.23M | -29.94M | -29.14M | -33.27M | -31.74M | -33.52M | -30.7M | -28.4M | -31.06M | -26.15M | -18.26M | -15.21M | -13.1M |
Net Income | -43.39M | -19.27M | -20.18M | -20.28M | -23.28M | -26.86M | -23.84M | -25.63M | -29.43M | -32.23M | -29.94M | -29.14M | -33.27M | -31.74M | -33.52M | -30.7M | -28.4M | -31.06M | -26.15M | -18.26M | -15.21M | -13.1M |
Selling & General & Admin | 5.41M | 5.45M | 5.98M | 5.57M | 6.71M | 6.46M | 5.96M | 6.36M | 6.05M | 6.55M | 5.59M | 4.85M | 5.66M | 5.23M | 5.95M | 4.74M | 5.98M | 5.7M | 4.1M | 4.3M | 3.33M | 2.83M |
Research & Development | 16.6M | 14.84M | 14.8M | 15.36M | 17.37M | 21.08M | 18.69M | 20.35M | 22.65M | 25.06M | 22.87M | 23.09M | 26.48M | 25.61M | 25.75M | 23.76M | 20.88M | 24.16M | 20.95M | 12.94M | 10.91M | 9.59M |
Other Expenses | 23.19M | -1.76M | 3.95M | n/a | -2.08M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 45.2M | 18.53M | 24.72M | 20.94M | 22M | 27.54M | 24.65M | 26.71M | 28.7M | 31.61M | 28.46M | 27.94M | 32.13M | 30.84M | 31.7M | 28.5M | 26.86M | 29.86M | 25.05M | 17.25M | 14.24M | 12.42M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 45.2M | 20.29M | 20.78M | 20.94M | 24.08M | 27.54M | 24.65M | 26.71M | 30.82M | 33.76M | 31.45M | 30.92M | 35.1M | 33.72M | 34.55M | 31.3M | 28.62M | 31.15M | 26.16M | 18.3M | 15.24M | 13.11M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 217.57M | 152.97M | 152.97M | 163.35M | 162.79M | 109.87M | 86.41M | 86.16M | 85.71M | 80.98M | 68.33M | 73.92M | 73.4M | 73.1M | 55.25M | 41.36M | 41.3M | 41.27M | 41.25M | 26.9M | 37.32M | 27.2M |
Shares Outstanding (Diluted) | 217.57M | 152.97M | 152.97M | 163.35M | 162.79M | 109.87M | 86.41M | 86.16M | 85.71M | 80.98M | 68.33M | 73.92M | 73.4M | 73.1M | 55.25M | 41.36M | 41.3M | 41.27M | 41.25M | 26.9M | 37.32M | 27.2M |
EPS (Basic) | -0.20 | -0.09 | -0.12 | -0.12 | -0.14 | -0.24 | -0.28 | -0.30 | -0.34 | -0.40 | -0.44 | -0.39 | -0.45 | -0.43 | -0.62 | -0.73 | -0.68 | -0.75 | -0.63 | -0.68 | -0.41 | -0.48 |
EPS (Diluted) | -0.20 | -0.09 | -0.12 | -0.12 | -0.14 | -0.24 | -0.28 | -0.30 | -0.34 | -0.40 | -0.44 | -0.39 | -0.45 | -0.43 | -0.62 | -0.73 | -0.68 | -0.75 | -0.63 | -0.68 | -0.41 | -0.48 |
EBITDA | -41.7M | -17.51M | -18.35M | -18.41M | -21.2M | -24.2M | -21.75M | -23.53M | -27.31M | -30.07M | -26.95M | -26.17M | -30.3M | -28.85M | -30.66M | -27.89M | -26.64M | -29.76M | -25.04M | -17.21M | -14.21M | -12.41M |
EBIT | -43.39M | -19.27M | -20.18M | -20.28M | -23.28M | -26.86M | -23.84M | -25.63M | -29.43M | -32.23M | -29.94M | -29.14M | -33.27M | -31.74M | -33.52M | -30.7M | -28.4M | -31.06M | -26.15M | -18.26M | -15.21M | -13.1M |
Depreciation & Amortization | 1.7M | 1.76M | 1.83M | 1.86M | 2.08M | 2.66M | 2.09M | 2.1M | 2.12M | 2.16M | 2.99M | 2.98M | 2.97M | 2.88M | 2.85M | 2.8M | 1.76M | 1.3M | 1.11M | 1.06M | 998K | 689K |
Add to Watchlist
Select watchlists to add or remove TNYA